15 minutes with: Eraj Shirvani, Isda

Derivatives practitioners are preparing themselves for a flood of new regulation that could fundamentally change the over-the-counter market.

The Basel Committee on Banking Supervision is finalising its changes to bank capital rules, dubbed Basel III, which will include a new charge on credit value adjustment, two liquidity ratios, requirements on quality of capital and a leverage ratio. The committee is also conducting a consultation on a counter-cyclical capital charge.

A final package of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: